EV
Insider
Eric Venker
President & Immunovant CEOEric Venker (President & Immunovant CEO) filed 17 Form 4 reports in the trailing twelve months (0 purchases, 17 sales, 1 filed past the two-business-day deadline), most often in Roivant Sciences Ltd. (ROIV). The largest single filing was $14.5M of ROIV (851,383 sh across 3 lots, as filed), executed Oct 15 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
17
0 buys · 17 sells · 1 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$90.2M
shares × price, as filed
Last traded
Aug 28
Filed Sep 1
Median ADV $222.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $155.0M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
16 filings
Sector per market data · by filing · past 12 months
Most traded names
ROIVRecent filings
ROIVSALE
Roivant Sciences Ltd.
View filing →
$5.3M200,000 sh × $26.49
Exec Feb 13
Filed Feb 18 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $4.4M
200,000 sh × $21.92
Exec Jan 12
Filed Jan 14 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $6.2M
275,000 sh across 2 lots
Exec Dec 23 2025
Filed Dec 29 2025 · 5:30 PM ET † ROIVSALE Roivant Sciences Ltd. View filing → $4.2M
200,000 sh × $20.85
Exec Dec 9 2025
Filed Dec 11 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $4.0M
200,000 sh × $20.22
Exec Nov 7 2025
Filed Nov 7 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $14.5M
851,383 sh across 3 lots
Exec Oct 15 2025
Filed Oct 17 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $2.0M
125,667 sh across 2 lots
Exec Oct 9 2025
Filed Oct 14 2025 · 5:30 PM ET ROIVSALE Roivant Sciences Ltd. View filing → $10.8M
665,159 sh across 3 lots
Exec Oct 6 2025
Filed Oct 8 2025 · 5:30 PM ET More filings →